retatrutide approval status 2025 fda This weight-loss drug hasn't been approved by the FDA. Doctors are prescribing it anyway The FDA has issued warning

In contrast, those with preclinical obesity can be managed with health counseling and monitoring to mitigate progression

At Gameday Mens Health in The Woodlands, these medications are offered as part of a clinician-guided approach for men seeking medical support for weight and metabolic concerns

[DOI] [PMC free article] [PubMed] [Google Scholar] 19.Gravina SA, Yep GL, Khan M

Considerable evidence documents that hyperglycemia is a weak risk factor for cardiovascular complications and improving glucose control has little benefit on macrovascular disease risk (UK Prospective Diabetes Study [UKPDS], Action to Control Cardiovascular Risk in Diabetes [ACCORD], Action in Diabetes and Vascular Disease: Preterax and Diamicron MR Controlled Evaluation [ADVANCE], Veterans Affairs Diabetes Trial [VADT]), especially when it is well established

Clinically, this is known as telogen effluvium and has been seen in some GLP-1 patients

Some patients who previously tried Ozempic and experienced intolerable side effects find that switching to Trulicity improves tolerability